Polfarma increased its stake in Russian pharma company
(firmenpresse) - The joint-stock company Polfarma Pharmaceutical Factory increased its stake in OJSC Integrated Chemical and Pharmaceutical Enterprise Akrikin from 72.54% to 98.17%.
Akrikhin is the fifth largest local producer by revenue 2010 and one of the fastest growing pharmaceutical companies on the Russian market. The Akrikhin revenue in 2011 grew by almost 18% from 3. 609 billion Rub to 4.254 billion Rub.
Chameleon Pharma Consulting comments: During the last year Polfarma has already acquired a big share in a leading pharmaceutical factory in Kazakhstan. But it is difficult for the company to achieve substantial growth in Poland. With this idea Polfarma seems to follow a strategy to move east in order to grow further. We also observe that these are mostly the CEE companies, which enter growing countries like Kazakhstan. Unfortunately, Pharma Players from western markets often use their existing Russian or Ukrainian partner to handle countries like Kazakhstan. We, Chameleon Pharma, always recommend to have a single good performing partner in Kazakhstan and to handle this interesting market directly.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Chameleon Pharma Consulting
Am Tempelhofer Berg 6
10965 Berlin
Germany
Tel: +49 30 648 35 163
Fax: +49 30 648 32 008
service(at)chameleon-pharma.com
www.chameleon-pharma.com
Ansprechpartner: Olga Kiefer
Tel: 030 648 35 164
E-mail: olki(at)chameleon-pharma.com
Chameleon Pharma Consulting is the healthcare and Pharma consulting expert for the CIS and Eastern European markets. Except for acquisition of targets and due diligence consulting, a part of the major business of Chameleon Pharma Consulting is the search for dynamic and highly-productive Healthcare sale and marketing partners on the CEE & GUS markets.
Datum: 12.03.2012 - 17:22 Uhr
Sprache: Deutsch
News-ID 123877
Anzahl Zeichen: 1143
contact information:
Contact person: Olga Kiefer
Town:
Berlin
Phone: 030 648 25164
Kategorie:
Healthcare & Medical
Typ of Press Release: Finanzinformation
type of sending: Veröffentlichung
Diese Pressemitteilung wurde bisher 524 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Polfarma increased its stake in Russian pharma company "
steht unter der journalistisch-redaktionellen Verantwortung von
Chameleon Pharma Consulting (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
